🟥 Member Webinar : Hemophilia Alliance Hosts – A Webinar from Takeda – VONVENDI® [von Willebrand Factor (Recombinant)] [Now] Approved for Adults and Pediatric Patients
Date: Wednesday, November 12th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: VONVENDI® Approved for Adults and Pediatric Patients. OBJECTIVE: Understand the underlying mechanism of VWD and the role of VWF. Review unmet needs in the treatment of VWD. Identify the unique characteristics of VONVENDI as the first and only recombinant treatment Read the full article...